Basilar artery diameter is a potential screening tool for fabry disease in young stroke patients

Cerebrovascular Diseases

Volumn 31, Issue 3, 2011, Pages 294-299

  Fellgiebel, Andreas ^a   Keller, Isabel ^a   Martus, Peter ^b,c   Ropele, Stefan ^b,e   Yakushev, Igor ^a   Böttcher, Tobias ^b,d   Fazekas, Franz ^b,e   Rolfs, Arndt ^b,d  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b Stroke in Young Fabry Patients Study Group   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY OF ROSTOCK   (Germany)

^e MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Basilar artery; Fabry disease; Young stroke patients

Indexed keywords

ADULT; ANTERIOR CEREBRAL ARTERY; AREA UNDER THE CURVE; ARTERY DIAMETER; ARTICLE; BASILAR ARTERY; CAROTID ARTERY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FABRY DISEASE; FEMALE; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY; POSTERIOR CEREBRAL ARTERY; PRIORITY JOURNAL; SCREENING TEST; SENSITIVITY AND SPECIFICITY; STROKE PATIENT;

ADULT; AGE FACTORS; ANALYSIS OF VARIANCE; BASILAR ARTERY; CASE-CONTROL STUDIES; CEREBRAL ANGIOGRAPHY; CHI-SQUARE DISTRIBUTION; DILATATION, PATHOLOGIC; FABRY DISEASE; FEMALE; GERMANY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MASS SCREENING; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; STROKE;

EID: 78650636568     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000322558     Document Type: Article

References (24)

1. Meikle PJ, Hopwood JJ, Clague AE, Carey WF: Prevalence of lysosomal storage disorders. JAMA 1999; 281: 249-254. (Pubitemid 29058114)
2. Fellgiebel A, Muller MJ, Ginsberg L: CNS manifestations of Fabry's disease. Lancet Neurol 2006; 5: 791-795. (Pubitemid 44205515)
3. Mehta A, Ginsberg L: Natural history of the cerebrovascular complications of Fabry disease. Acta Paediatr Suppl 2005; 94(447):24- 27, discussion 9-10.
4. Sims K, Politei J, Banikazemi M, Lee P: Stroke in Fabry disease frequently occurs before diagnosis and in the absence of other clinical events: natural history data from the Fabry Registry. Stroke 2009; 40: 788-794.
5. Fellgiebel A, Keller I, Marin D, et al: Diagnostic utility of different MRI and MR angiography measures in Fabry disease. Neurology 2009; 72: 63-68.
6. Rolfs A, Bottcher T, Zschiesche M, et al: Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study. Lancet 2005; 366: 1794-1796. (Pubitemid 41642643)
7. Brouns R, Thijs V, Eyskens F, et al: Belgian Fabry study: prevalence of Fabry disease in a cohort of 1,000 young patients with cerebrovascular disease. Stroke 2010; 41: 863-868.
8. Adams HP Jr, Bendixen BH, Kappelle LJ, et al: Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. TOAST, Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35-41. (Pubitemid 23014379)
9. Whybra C, Kampmann C, Krummenauer F, et al: The Mainz Severity Score Index: a new instrument for quantifying the Anderson- Fabry disease phenotype, and the response of patients to enzyme replacement therapy. Clin Genet 2004; 65: 299-307. (Pubitemid 38443553)
10. Albrecht J, Dellani PR, Muller MJ, et al: Voxel based analyses of diffusion tensor imaging in Fabry disease. J Neurol Neurosurg Psychiatry 2007; 78: 964-969. (Pubitemid 47310833)
11. Mitsias P, Levine SR: Cerebrovascular complications of Fabry's disease. Ann Neurol 1996; 40: 8-17. (Pubitemid 26250137)
12. Moore DF, Kaneski CR, Askari H, Schiffmann R: The cerebral vasculopathy of Fabry disease. J Neurol Sci 2007; 257: 258-263. (Pubitemid 46856501)
13. Wozniak MA, Kittner SJ, Tuhrim S, et al: Frequency of unrecognized Fabry disease among young European-American and African- American men with first ischemic stroke. Stroke 2010; 41: 78-81.
14. Hilz MJ, Kolodny EH, Brys M, Stemper B, Haendl T, Marthol H: Reduced cerebral blood flow velocity and impaired cerebral autoregulation in patients with Fabry disease. J Neurol 2004; 251: 564-570. (Pubitemid 38680299)
15. Moore DF, Altarescu G, Barker WC, Patronas NJ, Herscovitch P, Schiffmann R: White matter lesions in Fabry disease occur in 'prior' selectively hypometabolic and hyperperfused brain regions. Brain Res Bull 2003; 62: 231-240. (Pubitemid 38091711)
16. Beck M, Ricci R, Widmer U, et al: Fabry disease: overall effects of agalsidase alfa treatment. Eur J Clin Invest 2004; 34: 838-844. (Pubitemid 39657931)
17. Moore DF, Altarescu G, Ling GS, et al: Elevated cerebral blood flow velocities in Fabry disease with reversal after enzyme replacement. Stroke 2002; 33: 525-531. (Pubitemid 34123400)
18. Runck F, Steiner RP, Bautz WA, Lell MM: MR imaging: influence of imaging technique and postprocessing on measurement of internal carotid artery stenosis. AJNR Am J Neuroradiol 2008; 29: 1736-1742.
19. Tarasow E, Abdulwahed Saleh Ali A, Lewszuk A, Walecki J: Measurements of the middle cerebral artery in digital subtraction angiography and MR angiography. Med Sci Monit 2007; 13(suppl 1):65-72.
20. Villablanca JP, Nael K, Habibi R, Nael A, Laub G, Finn JP: 3 T contrast-enhanced magnetic resonance angiography for evaluation of the intracranial arteries: comparison with time-of-flight magnetic resonance angiography and multislice computed tomography angiography. Invest Radiol 2006; 41: 799-805. (Pubitemid 44564024)
21. Beckmann N, Stirnimann R, Bochelen D: High-resolution magnetic resonance angiography of the mouse brain: application to murine focal cerebral ischemia models. J Magn Reson 1999; 140: 442-450. (Pubitemid 129608306)
22. Reese T, Bochelen D, Sauter A, Beckmann N, Rudin M: Magnetic resonance angiography of the rat cerebrovascular system without the use of contrast agents. NMR Biomed 1999; 12: 189-196. (Pubitemid 29325665)
23. Ballabio E, Bersano A, Bresolin N, Candelise L: Monogenic vessel diseases related to ischemic stroke: a clinical approach. J Cereb Blood Flow Metab 2007; 27: 1649-1662. (Pubitemid 47476103)
24. Ikeda K, Nakamura Y, Hirayama T, et al: Cardiovascular risk and neuroradiological profiles in asymptomatic vertebrobasilar dolichoectasia. Cerebrovasc Dis 2010; 30: 23-28.